These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 27614591)

  • 21. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential versus concomitant surgery of glaucoma drainage implant and Boston keratoprosthesis type 1.
    Patel V; Moster MR; Kishfy L; Barkan J; Zhan T; Raber IM; Ayres BD; Pro MJ; Waisbourd M
    Eur J Ophthalmol; 2016 Nov; 26(6):556-563. PubMed ID: 27079206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort.
    Senthil S; Mohamed A; Shanbhag SS; Durgam SS; Bagga B; Sangwan VS; Basu S
    Cornea; 2022 May; 41(5):552-561. PubMed ID: 35383615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.
    Paschalis EI; Taniguchi EV; Chodosh J; Pasquale LR; Colby K; Dohlman CH; Shen LQ
    Curr Eye Res; 2019 Jun; 44(6):599-606. PubMed ID: 30632412
    [No Abstract]   [Full Text] [Related]  

  • 32. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.
    Ayyala RS; Pieroth L; Vinals AF; Goldstein MH; Schuman JS; Netland PA; Dreyer EB; Cooper ML; Mattox C; Frangie JP; Wu HK; Zurakowski D
    Ophthalmology; 1998 Aug; 105(8):1550-6. PubMed ID: 9709773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Total Pars Plana Vitrectomy on Postoperative Complications in Aphakic, Snap-On, Type 1 Boston Keratoprosthesis.
    Perez VL; Leung EH; Berrocal AM; Albini TA; Parel JM; Amescua G; Alfonso EC; Ali TK; Gibbons A
    Ophthalmology; 2017 Oct; 124(10):1504-1509. PubMed ID: 28528012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
    Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
    Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of Sequential Glaucoma Drainage Device Implantation Versus Cyclophotocoagulation Following Failure of a Primary Drainage Device.
    Levinson JD; Giangiacomo AL; Beck AD; Pruett PB; Superak HM; Lynn MJ; Costarides AP
    J Glaucoma; 2017 Apr; 26(4):311-314. PubMed ID: 26859357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the implantation of a Boston type 1 keratoprosthesis and a glaucoma drainage device in a nanophthalmic eye.
    Senthil S; Turaga K; Kumar R; Sangwan VS
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25274559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term outcomes of Boston keratoprosthesis].
    Mori Y; Nejima R; Minami K; Miyata K; Kamiya K; Fukud M
    Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):35-43. PubMed ID: 23424974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.
    Ali MH; Dikopf MS; Finder AG; Aref AA; Vajaranant T; de la Cruz J; Cortina MS
    Cornea; 2018 May; 37(5):602-608. PubMed ID: 29474296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.